GO:0001972 retinoic acid binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0001972 (retinoic acid binding) describes the molecular function of selectively binding retinoic acid, a vitamin A-derived signaling molecule.
• Cellular retinoic acid-binding proteins (CRABP1 and CRABP2) are the principal intracellular proteins that carry out retinoic acid binding.
• Retinoic acid binding by CRABP2 induces structural rigidification and dimerization, which affects its interactions and function.
• CRABP2 delivers retinoic acid to nuclear retinoic acid receptors, while CRABP1 modulates retinoic acid availability and degradation.
• Dysregulation of retinoic acid binding is implicated in solid tumors, developmental defects, and germ cell proliferation.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable precise dissection of retinoic acid binding function in cells and organisms.
Description
Retinoic acid binding (GO:0001972) is a molecular function that enables a protein to selectively and non-covalently interact with retinoic acid, a metabolite of vitamin A that acts as a potent regulator of gene expression, cell differentiation, and development. This function is essential for interpreting retinoic acid signals within cells and for maintaining appropriate concentrations of the ligand. Researchers study retinoic acid binding to understand how cells decode retinoid signals in normal physiology and how disruptions contribute to diseases such as cancer and developmental disorders. The primary proteins annotated with this function are the cellular retinoic acid-binding proteins (CRABPs), which are small cytosolic carriers that bind retinoic acid with high affinity and participate in both genomic and non-genomic signaling pathways. Because retinoic acid is a lipophilic molecule that requires chaperones for solubility and targeted delivery, retinoic acid binding proteins are central to retinoid biology. This article provides a comprehensive overview of the GO:0001972 function, its mechanisms, associated genes, disease relevance, and modern research methods including CRISPR-based models.
retinoic acid binding At A Glance
| GO ID | GO:0001972 |
|---|---|
| GO term | retinoic acid binding |
| Ontology | molecular_function |
| Synonym | (none) |
| Major function | Binding to retinoic acid, enabling its transport, signaling, and regulation of concentration |
| Major proteins | CRABP1, CRABP2, and other retinoic acid-binding proteins |
| Cellular context | Cytosol, nucleus, and extracellular space depending on the protein |
| Related processes | Retinoic acid signaling, cell differentiation, embryonic development, germ cell proliferation |
What Is GO:0001972?
GO:0001972 (retinoic acid binding) is defined as the molecular function of binding to retinoic acid, chemically known as 3,7-dimethyl-9-(2,6,-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid. In practical terms, it refers to the ability of a protein to recognize and reversibly associate with retinoic acid through non-covalent interactions, thereby facilitating its transport, signaling, or metabolism.
Why Is retinoic acid binding Important in Cell Biology?
Retinoic acid binding is critical for translating vitamin A signals into precise cellular responses, including differentiation, proliferation, and apoptosis. Dysregulation of this function can lead to aberrant retinoic acid signaling, which is associated with cancer progression, developmental abnormalities, and impaired germ cell development. Understanding retinoic acid binding at the molecular level informs therapeutic strategies that target retinoid pathways, such as in acute promyelocytic leukemia and solid tumors.
• Controls the availability of retinoic acid for nuclear receptor activation and gene regulation.
• Modulates retinoic acid degradation by cytochrome P450 enzymes, thereby influencing local ligand concentrations.
• Essential for embryonic development, including limb patterning and neurogenesis.
• Regulates germ cell proliferation and sex determination in zebrafish.
• Implicated in solid tumor biology, where CRABP2 expression is often altered.
• Participates in noncanonical retinoic acid signaling independent of nuclear receptors.
• Provides a mechanism for cells to buffer and transport hydrophobic retinoic acid in aqueous environments.
• Serves as a target for pharmacological modulation in differentiation therapy.
What Happens During retinoic acid binding?
Ligand recognition and initial binding
In simple terms: The protein grabs retinoic acid from its surroundings.
Cellular retinoic acid-binding proteins (CRABPs) possess a hydrophobic pocket that accommodates retinoic acid with high specificity. Binding occurs through non-covalent interactions, primarily hydrophobic and van der Waals forces, which stabilize the ligand within the binding site. This initial recognition step is crucial for solubilizing retinoic acid in the aqueous cytosol and preventing its nonspecific interactions.
Conformational changes and dimerization
In simple terms: The protein changes shape and pairs up after binding retinoic acid.
Retinoic acid binding induces structural rigidification of CRABP2 and promotes its dimerization, as shown by biochemical and structural studies. This conformational change can alter the protein's interactions with partner proteins, influencing downstream signaling. Dimerization may also affect the stability and subcellular localization of the protein.
Transport and delivery to nuclear receptors
In simple terms: The protein carries retinoic acid to the nucleus to activate gene expression.
CRABP2 shuttles retinoic acid into the nucleus, where it transfers the ligand to retinoic acid receptors (RARs), facilitating transcriptional activation of target genes. This delivery mechanism ensures that retinoic acid reaches its nuclear targets efficiently, linking cytoplasmic binding to genomic responses.
Modulation of retinoic acid degradation
In simple terms: Binding proteins can protect retinoic acid from being broken down or hand it over to degrading enzymes.
CRABPs interact with retinoic acid-degrading enzymes such as CYP26, influencing the local concentration of retinoic acid. By sequestering or presenting retinoic acid to these enzymes, binding proteins play a key role in maintaining retinoid homeostasis. This interplay is essential for preventing teratogenic effects of excess retinoic acid.
Non-genomic signaling functions
In simple terms: Binding proteins can also trigger rapid cellular responses without directly affecting gene expression.
Beyond nuclear delivery, retinoic acid binding proteins participate in noncanonical signaling pathways that operate independently of retinoic acid receptors. These non-genomic functions can modulate kinase cascades and other rapid cellular responses, adding complexity to retinoid biology.
Key Genes Involved in GO:0001972 retinoic acid binding
The following genes encode proteins that directly bind retinoic acid or are closely associated with this molecular function, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CRABP1 | Cytosolic retinoic acid binding and sequestration | Modulates retinoic acid availability; implicated in cancer and development |
| CRABP2 | Nuclear delivery of retinoic acid to RARs | Key mediator of genomic retinoic acid signaling; target in solid tumors |
| RBP1 | Cellular retinol-binding protein, facilitates retinol uptake | Indirectly affects retinoic acid synthesis and binding |
| RBP4 | Plasma retinol-binding protein, transports retinol | Systemic retinol transport, influences retinoic acid levels |
| ALDH1A1 | Retinaldehyde dehydrogenase, synthesizes retinoic acid | Produces ligand for binding proteins |
| ALDH1A2 | Retinaldehyde dehydrogenase, synthesizes retinoic acid | Critical for embryonic retinoic acid production |
| CYP26A1 | Retinoic acid 4-hydroxylase, degrades retinoic acid | Interacts with binding proteins to control retinoic acid levels |
| CYP26B1 | Retinoic acid degrading enzyme | Regulates germ cell development and sex determination |
| RARA | Nuclear retinoic acid receptor alpha | Receives retinoic acid from CRABP2; mediates gene regulation |
| RARB | Nuclear retinoic acid receptor beta | Participates in retinoic acid signaling |
| RARG | Nuclear retinoic acid receptor gamma | Mediates retinoic acid effects in development |
| RXRA | Retinoid X receptor alpha, heterodimer partner | Forms heterodimers with RARs to bind DNA |
| RXRB | Retinoid X receptor beta | Alternative heterodimer partner |
| RXRG | Retinoid X receptor gamma | Tissue-specific retinoid signaling |
| FABP5 | Fatty acid binding protein 5, binds retinoic acid | Alternative retinoic acid carrier in noncanonical signaling |
| PDK1 | 3-phosphoinositide dependent protein kinase-1 | Part of noncanonical retinoic acid signaling pathway |
| PPARβ/δ | Peroxisome proliferator-activated receptor beta/delta | Mediates noncanonical retinoic acid effects |
How Is retinoic acid binding Regulated?
Retinoic acid binding is regulated at multiple levels. The expression of CRABP1 and CRABP2 is controlled by retinoic acid itself through feedback mechanisms involving retinoic acid receptors. Additionally, the availability of retinoic acid is modulated by synthesis enzymes (ALDH1A1/2) and degradation enzymes (CYP26 family), which directly impact the amount of ligand available for binding. Post-translational modifications and protein-protein interactions, such as dimerization of CRABP2 upon ligand binding, further regulate the function of these binding proteins. Noncanonical signaling pathways involving FABP5 and PPARβ/δ also influence retinoic acid binding outcomes.
retinoic acid binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CRABP2 | Solid tumors, cancer progression | CRABP2 knockout and overexpression in cancer cell lines |
| CRABP1 | Cancer, developmental defects | CRABP1 knockout mouse models |
| ALDH1A2 | Developmental abnormalities | Knockout zebrafish or mouse embryos |
| CYP26B1 | Germ cell defects, sex determination | Zebrafish knockout models |
| FABP5 | Noncanonical retinoic acid signaling in cancer | FABP5 knockdown and overexpression studies |
Cancer
Altered expression of CRABP2 has been observed in various solid tumors, where it can influence cell proliferation, differentiation, and response to retinoid therapy. CRABP2 is considered a potential biomarker and therapeutic target in cancers such as breast, prostate, and head and neck cancers. The balance between CRABP1 and CRABP2 may determine whether cells undergo differentiation or remain malignant.
Developmental disorders
Retinoic acid binding proteins are essential for embryonic development, and their dysfunction can lead to congenital anomalies affecting the limbs, heart, and central nervous system. Proper spatiotemporal regulation of retinoic acid binding ensures correct patterning and organogenesis.
Germ cell and reproductive biology
In zebrafish, CRABP proteins regulate germ cell proliferation and sex determination, highlighting their role in reproductive development. Disruption of retinoic acid binding can lead to impaired gametogenesis and skewed sex ratios.
Neurodegeneration
Retinoic acid signaling is important for neuronal differentiation and survival, and dysregulation of retinoic acid binding proteins has been linked to neurodegenerative conditions, although the exact mechanisms remain under investigation.
From retinoic acid binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does CRABP2 loss affect retinoic acid signaling and tumor growth? | CRABP2 knockout cancer cell lines and xenografts |
| How does a point mutation in the retinoic acid binding pocket alter ligand affinity? | CRABP2 point-mutant knock-in cell lines |
| What is the effect of CRABP2 overexpression on differentiation? | CRABP2 overexpression in stem cells or cancer cells |
| Can tagged CRABP2 be used to track subcellular localization? | CRABP2 knock-in with fluorescent tag |
| What is the role of CRABP1 in retinoic acid homeostasis? | CRABP1 knockout mouse models |
| How do CRABP proteins regulate germ cell proliferation? | Zebrafish crabp knockout models |
How to Study the retinoic acid binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Isothermal titration calorimetry | Binding affinity and thermodynamics | Characterizing CRABP-retinoic acid interactions |
| Fluorescence titration | Dissociation constant (Kd) | Comparing wild-type and mutant binding proteins |
| X-ray crystallography | Three-dimensional structure | Visualizing ligand-bound CRABP2 |
| RNA-seq | Transcriptional changes | Identifying retinoic acid-responsive genes |
| CRISPR knockout screens | Gene essentiality and modifiers | Discovering regulators of retinoic acid binding |
| Proximity ligation assay | Protein-protein interactions | Detecting CRABP2-RAR interactions |
| Live-cell imaging | Subcellular localization | Tracking tagged CRABP2 trafficking |
| Zebrafish transgenesis | In vivo function | Studying germ cell and developmental roles |
Ligand binding assays
Direct measurement of retinoic acid binding affinity can be performed using fluorescence titration, isothermal titration calorimetry, or radioligand binding assays. These methods quantify dissociation constants and reveal structural requirements for binding.
Structural biology
X-ray crystallography and NMR spectroscopy provide atomic-level insights into the retinoic acid binding pocket and conformational changes upon ligand binding. Such studies have revealed the rigidification and dimerization of CRABP2.
Gene expression analysis
RNA-seq and qPCR can assess the impact of retinoic acid binding on downstream target genes, including those regulated by retinoic acid receptors. This helps link binding events to transcriptional outcomes.
CRISPR-based genetic screens
Pooled CRISPR knockout screens can identify genes that modulate retinoic acid binding and signaling, uncovering novel regulators and potential therapeutic targets.
How CRISPR Can Be Used to Study GO:0001972 retinoic acid binding
Knockout
CRISPR-Cas9 knockout of CRABP1 or CRABP2 in cell lines and animal models enables loss-of-function studies to determine their roles in retinoic acid signaling, proliferation, and differentiation. Knockout zebrafish models have revealed essential functions in germ cell development.
Point Mutation
Introducing specific point mutations in the retinoic acid binding pocket of CRABP2 via CRISPR base editing or homology-directed repair allows precise testing of residues critical for ligand binding and conformational changes. Such models help distinguish binding-dependent from independent functions.
Knock-in
Knock-in of epitope tags or fluorescent proteins into the endogenous CRABP2 locus facilitates real-time tracking of protein localization and interactions without overexpression artifacts. This approach preserves native regulation and provides physiological relevance.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of CRABP2 can model elevated retinoic acid binding in cancer and assess its impact on differentiation and tumor growth. Overexpression studies complement knockout approaches to reveal dosage effects.
How EDITGENE Supports retinoic acid binding Research
Researchers studying retinoic acid binding-related genes often need to determine whether a candidate gene is causally involved in retinoid signaling, differentiation, or disease. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell and animal models, enabling rigorous functional interrogation of GO:0001972 and its associated pathways.
Contact EDITGENE today to design your custom CRISPR model for retinoic acid binding research.
Frequently Asked Questions About retinoic acid binding
What is retinoic acid binding?
Retinoic acid binding (GO:0001972) is the molecular function of selectively binding retinoic acid, a vitamin A derivative that regulates gene expression and development.
What genes are involved in retinoic acid binding?
The main genes are CRABP1 and CRABP2, which encode cellular retinoic acid-binding proteins, along with RBP1, RBP4, ALDH1A1/2, and CYP26 family members that influence ligand availability.
What is the function of CRABP2?
CRABP2 binds retinoic acid and delivers it to nuclear retinoic acid receptors, facilitating transcriptional activation; it also undergoes conformational changes and dimerization upon binding.
How does retinoic acid binding affect cancer?
Altered CRABP2 expression is observed in solid tumors and can influence proliferation, differentiation, and response to retinoid therapy, making it a potential biomarker and target.
What diseases are associated with retinoic acid binding proteins?
Dysregulation is linked to solid tumors, developmental disorders, germ cell defects, and potentially neurodegeneration.
How can I study retinoic acid binding using CRISPR?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise manipulation of CRABP genes to test their roles in signaling and disease.
What methods measure retinoic acid binding affinity?
Isothermal titration calorimetry, fluorescence titration, and radioligand binding assays are commonly used to quantify binding affinity.
What is the role of CRABP1 versus CRABP2?
CRABP1 is primarily cytosolic and modulates retinoic acid availability and degradation, while CRABP2 delivers retinoic acid to the nucleus for genomic signaling.
Can retinoic acid binding occur outside the nucleus?
Yes, noncanonical retinoic acid signaling involves cytoplasmic binding proteins like FABP5 and CRABP1, which can activate pathways independent of nuclear receptors.
How do retinoic acid binding proteins regulate germ cell development?
In zebrafish, CRABP proteins regulate germ cell proliferation and sex determination, and their knockout leads to impaired gametogenesis.
Conclusion
Retinoic acid binding (GO:0001972) is a fundamental molecular function that governs how cells interpret vitamin A signals. The cellular retinoic acid-binding proteins CRABP1 and CRABP2 are central to this function, controlling ligand availability, nuclear delivery, and noncanonical signaling. Dysregulation of retinoic acid binding contributes to cancer, developmental defects, and reproductive disorders, underscoring its clinical relevance. Advances in CRISPR-based models and structural biology continue to unravel the precise mechanisms and therapeutic potential of targeting retinoic acid binding in human disease.
References
- 1. Jiao X et al.. 2020. Cellular Retinoic-Acid Binding Protein 2 in Solid Tumor.. Curr Protein Pept Sci 21(5):507-516 PMID: 32013828
- 2. Lixa C et al.. 2019. Retinoic Acid Binding Leads to CRABP2 Rigidification and Dimerization.. Biochemistry 58(41):4183-4194 PMID: 31566355
- 3. Wei LN. 2016. Cellular Retinoic Acid Binding Proteins: Genomic and Non-genomic Functions and their Regulation.. Subcell Biochem 81:163-178 PMID: 27830504
- 4. Piletta P et al.. 1993. Cellular retinoic acid-binding proteins (CRABP).. Exp Dermatol 2(5):191-5 PMID: 8162338
- 5. Isoherranen N et al.. 2025. The interplay between retinoic acid binding proteins and retinoic acid degrading enzymes in modulating retinoic acid concentrations.. Curr Top Dev Biol 161:167-200 PMID: 39870433
- 6. Donovan M et al.. 1995. The cellular retinoic acid binding proteins.. J Steroid Biochem Mol Biol 53(1-6):459-65 PMID: 7626495
- 7. Fung L et al.. 2024. Cellular retinoic acid-binding proteins regulate germ cell proliferation and sex determination in zebrafish.. Development 151(24) PMID: 39575928
- 8. Nhieu J et al.. 2020. Noncanonical retinoic acid signaling.. Methods Enzymol 637:261-281 PMID: 32359648
